Vercise™ Pc Dbs System Description; Intended Use / Indications For Use - Boston Scientific Vercise PC Instrucciones De Uso

Ocultar thumbs Ver también para Vercise PC:
Tabla de contenido

Publicidad

Vercise™ PC DBS System Description
The Vercise PC Deep Brain Stimulation (DBS) System includes a Stimulator with DBS Leads
for unilateral or bilateral stimulation. There are also DBS Extensions that allow the DBS Leads
mounted in the skull to be extended to reach the Stimulator implanted near the clavicle. The
Vercise PC DBS System utilizes current steering across eight contacts per DBS Lead to provide
precise positioning of stimulation. The Stimulator is controlled by a hand-held Remote Control, and
can be interfaced with a Clinician's Programmer.
The battery of the non-rechargeable stimulator will become depleted. The longevity of the
Stimulator battery depends on the following factors:
Programmed parameters
System impedance
Hours per day of stimulation
Changes to stimulation made by the patient
For additional information on estimating the longevity of the non-rechargeable battery, refer to the
appropriate programming manual as listed on your DBS Reference Guide.
Note: The Vercise PC System was not made with natural latex.

Intended Use / Indications for Use

The Vercise PC DBS System is indicated for use in the following:
Unilateral or bilateral stimulation of the subthalamic nucleus (STN) or internal globus
pallidus (GPi) for treatment of levodopa-responsive Parkinson's disease which is not
adequately controlled with medication.
Unilateral or bilateral stimulation of the subthalamic nucleus (STN) or internal globus
pallidus (GPi) for treatment of intractable primary and secondary dystonia, for persons 7
years of age and older.
Thalamic stimulation for the suppression of tremor not adequately controlled by
medications in patients diagnosed with Essential Tremor or Parkinson's disease.
Unilateral or bilateral stimulation of the post-commissural fornix in the treatment of
patients 65 years and older with mild probable Alzheimer's disease, as an adjunctive
therapy for patients on a stable dose of cholinesterase inhibitor medication.
Vercise™ PC DBS System Description
Vercise™ PC Information for Prescribers
92190993-02 1 of 459

Publicidad

Tabla de contenido
loading

Tabla de contenido